1-30874496-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_014654.4(SDC3):c.963A>G(p.Glu321Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
SDC3
NM_014654.4 synonymous
NM_014654.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.46
Genes affected
SDC3 (HGNC:10660): (syndecan 3) The protein encoded by this gene belongs to the syndecan proteoglycan family. It may play a role in the organization of cell shape by affecting the actin cytoskeleton, possibly by transferring signals from the cell surface in a sugar-dependent mechanism. Allelic variants of this gene have been associated with obesity. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 1-30874496-T-C is Benign according to our data. Variant chr1-30874496-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 760302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.46 with no splicing effect.
BS2
High AC in GnomAdExome4 at 57 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDC3 | NM_014654.4 | c.963A>G | p.Glu321Glu | synonymous_variant | Exon 4 of 5 | ENST00000339394.7 | NP_055469.3 | |
SDC3 | XM_011542463.1 | c.930A>G | p.Glu310Glu | synonymous_variant | Exon 4 of 5 | XP_011540765.1 | ||
SDC3 | XM_011542464.3 | c.927A>G | p.Glu309Glu | synonymous_variant | Exon 4 of 5 | XP_011540766.1 | ||
SDC3 | XM_011542466.2 | c.837A>G | p.Glu279Glu | synonymous_variant | Exon 4 of 5 | XP_011540768.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDC3 | ENST00000339394.7 | c.963A>G | p.Glu321Glu | synonymous_variant | Exon 4 of 5 | 1 | NM_014654.4 | ENSP00000344468.6 | ||
SDC3 | ENST00000336798.11 | c.789A>G | p.Glu263Glu | synonymous_variant | Exon 2 of 3 | 1 | ENSP00000338346.7 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000835 AC: 21AN: 251468 AF XY: 0.000110 show subpopulations
GnomAD2 exomes
AF:
AC:
21
AN:
251468
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727248 show subpopulations
GnomAD4 exome
AF:
AC:
57
AN:
1461874
Hom.:
Cov.:
32
AF XY:
AC XY:
40
AN XY:
727248
Gnomad4 AFR exome
AF:
AC:
0
AN:
33480
Gnomad4 AMR exome
AF:
AC:
0
AN:
44718
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26134
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
49
AN:
86256
Gnomad4 FIN exome
AF:
AC:
0
AN:
53418
Gnomad4 NFE exome
AF:
AC:
6
AN:
1112008
Gnomad4 Remaining exome
AF:
AC:
1
AN:
60394
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74326
Gnomad4 AFR
AF:
AC:
0
AN:
0
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207211
AN:
0.000207211
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000146998
AN:
0.0000146998
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 17, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=98/2
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at